Lawsuit Accuses Gilead of Sitting on Safer HIV Drugs to Maximize Profit

Drug Industry Daily
A A
A federal lawsuit accuses Gilead of deliberately keeping a safer version of its HIV drug Tenofovir disoproxil fumarate (TDF) off the market until patent exclusivity ends for the original.

To View This Article:

Login

Subscribe To Drug Industry Daily